StockVS

Nu Skin Enterprises, Inc. (NUS) 股票分析

防御性消费

Nu Skin Enterprises, Inc.

$5.89

$-0.04 (-0.67%)

最后更新: 2026年5月26日

价格走势

最新新闻

新闻由第三方来源提供。不构成投资建议。

分析

公司概述

Nu Skin Enterprises, Inc. engages in the global development and distribution of beauty and wellness products, offering a portfolio that includes skin care devices such as the ageLOC LumiSpa series, cosmetics, and personal care items like RenuSpa iO. The company operates within the Consumer Defensive sector and the Household & Personal Products industry, positioning itself as a provider of essential personal care solutions with a defensive characteristic that often appeals to capital during market volatility. As of the latest data, the enterprise holds a market capitalization of $358.50M and generates annual revenue of $1.49B while employing a workforce of 2,800 individuals across its operational footprint. These valuation and revenue figures indicate that Nu Skin is a mid-sized entity within its specific niche, suggesting a capitalization that reflects a mature business model rather than a high-growth technology startup, with revenue levels that support a stable but limited scale relative to large-cap consumer giants.

财务健康

The company reported a trailing twelve-month revenue of $1.49B, generating net income of $160.20M and an EBITDA of $143.14M, revealing a cost structure where operating expenses and taxes consume a significant portion of gross sales to arrive at final profit. Free cash flow stands at $90.95M, which provides the company with substantial financial flexibility to manage capital expenditures, service debt obligations, or fund operations without immediate reliance on external financing. Gross margin is reported at 69.4%, indicating a highly efficient pricing power or cost control in the manufacturing and distribution of its beauty products. Operating margin sits at 6.3%, reflecting the broader overhead costs required to run a global supply chain, while profit margin reaches 10.8%, demonstrating the company's ability to convert a meaningful portion of revenue into bottom-line earnings. On the balance sheet, total cash assets of $241.96M are compared against total debt of $308.64M, resulting in a debt-to-equity ratio of 38.33%, which suggests a leveraged position where debt exceeds cash reserves but remains within manageable parameters for the industry. The current ratio of 2.08 indicates robust short-term liquidity, as current assets are more than double current liabilities, ensuring the ability to meet obligations as they come due. Return on Equity stands at 22.0%, highlighting effective utilization of shareholder capital, whereas Return on Assets is 4.0%, reflecting the efficiency of the entire asset base in generating returns relative to its size.

估值评估

The trailing twelve-month P/E ratio is 2.29, while the forward P/E is projected at 5.56, implying that the market expects earnings to increase significantly in the future to justify the higher multiple. The price-to-book ratio is 0.44, indicating that the stock trades at a substantial discount to its book value, which often signals that the market is pricing in potential risks or that the asset base is undervalued relative to market price. Alternative valuation metrics include a price-to-sales ratio of 0.24 and an EV/EBITDA of 2.92, suggesting that the company is valued very conservatively relative to its sales and earnings generation capabilities. The 52-week trading range spans from a low of $5.32 to a high of $14.62, providing a context for price volatility and historical performance boundaries. The beta value is 1.07, meaning the stock's price volatility is slightly higher than the broader market, suggesting that price movements will generally track the market index but with amplified swings during periods of market stress.

Growth & Income

Revenue growth year-over-year is -16.9%, while earnings growth year-over-year is N/A, indicating that the company is currently facing a contraction in top-line sales which impacts the trajectory of profitability. Since earnings growth data is not available for comparison, it is unclear if earnings are growing faster or slower than revenue, but the negative revenue growth suggests a challenging sales environment that requires strategic adjustments. Nu Skin Enterprises, Inc. pays a dividend with a yield of 3.3% and maintains a payout ratio of 7.6%, which indicates a highly sustainable dividend policy given that the payout represents only a small fraction of the generated earnings. The overall growth and income profile presents a mixed picture of a company delivering a consistent income stream through a modest dividend yield while simultaneously navigating a period of declining revenue that may constrain future capital allocation options.

同行比较

Nu Skin Enterprises, Inc. (NUS) 在家庭与个人护理产品行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Nu Skin Enterprises, Inc. NUS $287.90M 5.5
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

家庭与个人护理产品行业平均市盈率为29.9倍。Nu Skin Enterprises, Inc.的市盈率为5.5。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

公司简介以英文显示。

访问官网 →

关键指标

市值
$287.90M
市盈率
5.49
52周最高
$14.62
52周最低
$5.62
平均成交量
543.17K
Beta系数
1.02
股息率
4.05%

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
2,800